Cana­di­an plant-based vac­cine de­vel­op­er Med­ica­go shut­ters months af­ter lay­offs

Plant-based Covid-19 vac­cine de­vel­op­er Med­ica­go shut down this week with lit­tle fan­fare. And its two sub­sidiaries, Med­ica­go R&D and Med­ica­go USA, are al­so clos­ing their doors, ac­cord­ing to a com­pa­ny news re­lease.

The lone share­hold­er left stand­ing, Japan-based Mit­subishi Chem­i­cal Group, “has de­ter­mined not to make fur­ther in­vest­ments in Med­ica­go and to pro­ceed with an or­der­ly wind-up of its busi­ness and op­er­a­tions in Cana­da and in the Unit­ed States.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER